Summary of Drugs and Manners of Administration Subject to Price Disclosure
pre-1 December 2010

Please note: The information on this page is no longer current and is only included here for historical reference. Up to date information can be found on the Price Disclosure (EAPD) page.

 

First Round of PBS Price Disclosure – Assessed for potential reduction on 1 December 2009
First Round of PBS Price Disclosure - December 2009
Drug MOA
amisulpride oral
doxorubicin injection/intravesical
fosinopril with hydrochlorothiazide oral
meloxicam oral
mitozantrone injection
ondansetron injection
oxybutynin oral
perindopril with indapamide oral
valproic acid oral

 

Second Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Second Round of PBS Price Disclosure – April 2010
Drug MOA
alendronic acid oral
ceftriaxone injection
fluconazole injection
fluconazole oral
naltrexone oral
vancomycin injection

 

Third Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Third Round of PBS Price Disclosure – April 2010
Drug MOA
carvedilol oral
enalapril with hydrochlorothiazide oral
irinotecan injection
sumatriptan oral

 

Fourth Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2010
Fourth Round of PBS Price Disclosure – August 2010
Drug MOA
amisulpride oral
bicalutamide oral
cefalotin injection
doxorubicin injection/intravesical
fosinopril with hydrochlorothiazide oral
meloxicam oral
mitozantrone injection
ondansetron injection
oxybutynin oral
perindopril with indapamide oral
valproic acid oral

 

Fifth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Fifth Round of PBS Price Disclosure – April 2011
Drug MOA
alendronic acid oral
ceftriaxone injection
cisplatin injection
fluconazole injection
fluconazole oral
fludarabine injection
naltrexone oral
risperidone oral
vancomycin injection

 

Sixth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Sixth Round of PBS Price Disclosure – April 2011
Drug MOA
carvedilol oral
enalapril with hydrochlorothiazide oral
gemcitabine injection
irinotecan injection
paclitaxel injection
sumatriptan oral
vinorelbine injection

 

Seventh Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2011
Seventh Round of PBS Price Disclosure – August 2011
Drug MOA
alendronic acid with colecalciferol oral
amisulpride oral
azithromycin oral
bicalutamide oral
bisoprolol oral
cabergoline oral
cefalotin injection
doxorubicin injection/intravesical
escitalopram oral
fosinopril with hydrochlorothiazide oral
glucose injection
meloxicam oral
mitozantrone injection
morphine oral
ondansetron injection
ondansetron oral
oxaliplatin injection
oxybutynin oral
perindopril with indapamide oral
sodium chloride injection
sodium lactate compound injection
valproic acid oral

 This list includes all drugs and manners of administration subject to price disclosure arrangements in each cycle pre-1 December 2010 (i.e. prior to arrangements becoming expanded and accelerated).  

Last updated
1 December 2010